These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 10651940)
1. Production and functional analysis of rat CD59 and chimeric CD59-Crry as active soluble proteins in Pichia pastoris. Quigg RJ; He C; Hack BK; Alexander JJ; Morgan BP Immunology; 2000 Jan; 99(1):46-53. PubMed ID: 10651940 [TBL] [Abstract][Full Text] [Related]
2. Production of the rat complement regulator, Crry, as an active soluble protein in Pichia pastoris. He C; Alexander JJ; Lim A; Quigg RJ Arch Biochem Biophys; 1997 May; 341(2):347-52. PubMed ID: 9169025 [TBL] [Abstract][Full Text] [Related]
3. Suppression of complement regulatory proteins (CRPs) exacerbates experimental autoimmune anterior uveitis (EAAU). Jha P; Sohn JH; Xu Q; Wang Y; Kaplan HJ; Bora PS; Bora NS J Immunol; 2006 Jun; 176(12):7221-31. PubMed ID: 16751365 [TBL] [Abstract][Full Text] [Related]
4. Crry and CD59 regulate complement in rat glomerular epithelial cells and are inhibited by the nephritogenic antibody of passive Heymann nephritis. Quigg RJ; Holers VM; Morgan BP; Sneed AE J Immunol; 1995 Apr; 154(7):3437-43. PubMed ID: 7534798 [TBL] [Abstract][Full Text] [Related]
5. Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins. Sohn JH; Kaplan HJ; Suk HJ; Bora PS; Bora NS Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3492-502. PubMed ID: 11006244 [TBL] [Abstract][Full Text] [Related]
6. Complement regulation in the rat glomerulus: Crry and CD59 regulate complement in glomerular mesangial and endothelial cells. Quigg RJ; Morgan BP; Holers VM; Adler S; Sneed AE; Lo CF Kidney Int; 1995 Aug; 48(2):412-21. PubMed ID: 7564108 [TBL] [Abstract][Full Text] [Related]
7. Production and functional characterization of a soluble recombinant form of mouse CD59. Rushmere NK; Van Den Berg CW; Morgan BP Immunology; 2000 Feb; 99(2):326-32. PubMed ID: 10692054 [TBL] [Abstract][Full Text] [Related]
9. CD59 protects rat kidney from complement mediated injury in collaboration with crry. Watanabe M; Morita Y; Mizuno M; Nishikawa K; Yuzawa Y; Hotta N; Morgan BP; Okada N; Okada H; Matsuo S Kidney Int; 2000 Oct; 58(4):1569-79. PubMed ID: 11012891 [TBL] [Abstract][Full Text] [Related]
10. Renal, central nervous system and pancreatic overexpression of recombinant soluble Crry in transgenic mice. A novel means of protection from complement-mediated injury. Alexander JJ; Lim A; He C; MacDonald RL; Holers VM; Quigg RJ Immunopharmacology; 1999 May; 42(1-3):245-54. PubMed ID: 10408385 [TBL] [Abstract][Full Text] [Related]
11. Activation of complement components and reduced regulator expression in alcohol-induced liver injury in the rat. Järveläinen HA; Väkevä A; Lindros KO; Meri S Clin Immunol; 2002 Oct; 105(1):57-63. PubMed ID: 12483994 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9. Rollins SA; Zhao J; Ninomiya H; Sims PJ J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395 [TBL] [Abstract][Full Text] [Related]
14. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack. Miwa T; Zhou L; Hilliard B; Molina H; Song WC Blood; 2002 May; 99(10):3707-16. PubMed ID: 11986227 [TBL] [Abstract][Full Text] [Related]
15. Expression of rat complement control protein Crry on tumor cells inhibits rat natural killer cell-mediated cytotoxicity. Caragine TA; Imai M; Frey AB; Tomlinson S Blood; 2002 Nov; 100(9):3304-10. PubMed ID: 12384431 [TBL] [Abstract][Full Text] [Related]
16. Specific collaboration between rat membrane complement regulators Crry and CD59 protects peritoneum from damage by autologous complement activation. Mizuno T; Mizuno M; Morgan BP; Noda Y; Yamada K; Okada N; Yuzawa Y; Matsuo S; Ito Y Nephrol Dial Transplant; 2011 Jun; 26(6):1821-30. PubMed ID: 21098015 [TBL] [Abstract][Full Text] [Related]
17. A tumor-expressed inhibitor of the early but not late complement lytic pathway enhances tumor growth in a rat model of human breast cancer. Caragine TA; Okada N; Frey AB; Tomlinson S Cancer Res; 2002 Feb; 62(4):1110-5. PubMed ID: 11861390 [TBL] [Abstract][Full Text] [Related]
18. Rat T cells express neither CD55 nor CD59 and are dependent on Crry for protection from homologous complement. Hanna S; Spiller O; Linton SM; Mead RJ; Morgan B Eur J Immunol; 2002 Feb; 32(2):502-9. PubMed ID: 11828367 [TBL] [Abstract][Full Text] [Related]
19. Identification of mutations in rat CD59 that increase the complement regulatory activity. Hinchliffe SJ; Morgan BP Biochemistry; 2000 May; 39(19):5831-7. PubMed ID: 10801333 [TBL] [Abstract][Full Text] [Related]
20. Identity of the segment of human complement C8 recognized by complement regulatory protein CD59. Lockert DH; Kaufman KM; Chang CP; Hüsler T; Sodetz JM; Sims PJ J Biol Chem; 1995 Aug; 270(34):19723-8. PubMed ID: 7544344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]